0001171843-18-001655.txt : 20180302
0001171843-18-001655.hdr.sgml : 20180302
20180302160615
ACCESSION NUMBER: 0001171843-18-001655
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180302
FILED AS OF DATE: 20180302
DATE AS OF CHANGE: 20180302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHERWOOD CHARLES H
CENTRAL INDEX KEY: 0001244298
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14027
FILM NUMBER: 18661957
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anika Therapeutics, Inc.
CENTRAL INDEX KEY: 0000898437
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043145961
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: (781) 457-9000
MAIL ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC
DATE OF NAME CHANGE: 19970114
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA RESEARCH INC
DATE OF NAME CHANGE: 19930309
4
1
formfour.xml
FORM 4
X0306
4
2018-03-02
0
0000898437
Anika Therapeutics, Inc.
ANIK
0001244298
SHERWOOD CHARLES H
32 WIGGINS AVENUE
BEDFORD
MA
01730
1
1
0
0
CEO and Director
Stock Option (Right to Buy)
50.13
2018-03-02
4
A
0
27984
0
A
2027-01-27
Common Stock
27984
27984
D
The exercise price of the stock options represents the closing price of the Company's common stock on the grant date, January 27, 2017, the date the Compensation Committee of the Company granted these performance-based stock option awards (the "Performance Grant"). Please also see notes 2 and 3.
On March 2, 2018, the Compensation Committee determined and certified that 55% of the initial Performance Grant had been earned, subject to time-based vesting. Please also see notes 1 and 3.
The stock options vest in three equal installments on the following dates: March 2, 2018, January 1, 2019, and January 1, 2020.
/s/ Charles H. Sherwood, Ph.D.
2018-03-02